文献速递血液净化与透析急性肾损伤

含磷酸盐与无磷酸盐溶液对需要连续性肾脏替代治疗患者机械通气天数的影响

Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-04-27

本研究为单中心回顾性前后队列研究,纳入992例接受连续性肾脏替代治疗和机械通气的成人重症患者,其中649例(65%)使用含磷酸盐溶液,343例(35%)使用无磷酸盐溶液。多变量模型显示,含磷酸盐溶液组28天内无机械通气天数增加12%(95%CI 0.17至0.47),ICU住院日减少17%(95%CI -0.08至-0.30),住院日减少20%(95%CI -0.12至-0.32),两组医院死亡率无差异。

要点

  • 含磷酸盐连续性肾脏替代治疗溶液与28天内无机械通气天数增加12%独立相关。
  • 含磷酸盐溶液组ICU住院日和住院日分别减少17%和20%,医院死亡率无差异。
  • 倾向性评分匹配分析结果与主分析一致。

核心结论

  • 使用含磷酸盐与无磷酸盐连续性肾脏替代治疗溶液相比,与更少的机械通气天数和更短的ICU住院时间独立相关。

研究设计与样本

  • 单中心、回顾性、前后对照队列研究,纳入ICU期间接受连续性肾脏替代治疗和机械通气的成人患者992例。

主要发现

  • 含磷酸盐溶液组649例(65%),无磷酸盐溶液组343例(35%)。
  • 多变量模型显示,含磷酸盐溶液组28天内无机械通气天数增加12%(95%CI 0.17至0.47)。
  • 含磷酸盐溶液组较无磷酸盐溶液组ICU住院日减少17%(95%CI -0.08至-0.30),住院日减少20%(95%CI -0.12至-0.32)。
  • 两组医院死亡率无差异。
  • 倾向性评分匹配分析中28天内无机械通气天数结果一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Hypophosphatemia is commonly observed in patients receiving continuous KRT. Patients who develop hypophosphatemia may be at risk of respiratory and neuromuscular dysfunction and therefore subject to prolongation of ventilator support. We evaluated the association of phosphate-containing versus phosphate-free continuous KRT solutions with ventilator dependence in critically ill patients receiving continuous KRT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study was a single-center, retrospective, pre-post cohort study of adult patients receiving continuous KRT and mechanical ventilation during their intensive care unit stay. Zero-inflated negative binomial regression with and without propensity score matching was used to model our primary outcome: ventilator-free days at 28 days. Intensive care unit and hospital lengths of stay as well as hospital mortality were analyzed with a t test or a chi-squared test, as appropriate. RESULTS: We identified 992 eligible patients, of whom 649 (65%) received phosphate-containing solutions and 343 (35%) received phosphate-free solutions. In multivariable models, patients receiving phosphate-containing continuous KRT solutions had 12% (95% confidence interval, 0.17 to 0.47) more ventilator-free days at 28 days. Patients exposed to phosphate-containing versus phosphate-free solutions had 17% (95% confidence interval, -0.08 to -0.30) fewer days in the intensive care unit and 20% (95% confidence interval, - 0.12 to -0.32) fewer days in the hospital. Concordant results were observed for ventilator-free days at 28 days in the propensity score matched analysis. There was no difference in hospital mortality between the groups. CONCLUSIONS: The use of phosphate-containing versus phosphate-free continuous KRT solutions was independently associated with fewer ventilator days and shorter stay in the intensive care unit.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Thompson Bastin ML, Stromberg AJ, Nerusu SN, et al. Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy. Clin J Am Soc Nephrol. 2022. PMID: 35477673. doi:10.2215/CJN.12410921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。